skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > glycosylceramide > n-[(4z)-1-/{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > glycosylceramide > n-[(4z)-1-/{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid
organooxygen compound > sphingolipid > ceramide > glycosylceramide > n-[(4z)-1-/{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > glycosylceramide > n-[(4z)-1-/{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid
organooxygen compound > carboxamide > ceramide > glycosylceramide > n-[(4z)-1-/{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > glycosylceramide > n-[(4z)-1-/{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > glycosylceramide > n-[(4z)-1-/{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > glycosylceramide > n-[(4z)-1-/{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > glycosylceramide > n-[(4z)-1-/{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > glycosylceramide > n-[(4z)-1-/{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid
organooxygen compound > sphingolipid > glycosphingolipid > glycosylceramide > n-[(4z)-1-/{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid

اصطلاح مرجح

n-[(4z)-1-/{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C54H103NO13

اینچی

  • InChI=1S/C54H103NO13/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-46(59)55-42(43(58)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2)41-65-53-51(64)49(62)52(45(40-57)67-53)68-54-50(63)48(61)47(60)44(39-56)66-54/h35,37,42-45,47-54,56-58,60-64H,3-34,36,38-41H2,1-2H3,(H,55,59)/b37-35-/t42?,43?,44-,45-,47+,48+,49-,50-,51-,52+,53-,54-/m1/s1

اینچی‌کی

  • KDEYEEYMIPNKIJ-AEPZXQGCSA-N

جرم

  • 974.412

جرم تک‌ایزوتوپی

  • 973.74294

اسمایلٓ

  • O([C@@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1CO)OCC(NC(=O)CCCCCCCCCCCCCCCCCCCCCCC)C(O)/C=C/CCCCCCCCCCCCC)[C@H]2O[C@@H]([C@H](O)[C@H](O)[C@H]2O)CO

زیرمجموعه

  • 2_STAR

مترادف دقیق

  • N-[(Z)-1-[(2R,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]tetracosanamide

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:184954

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD